Please enable JavaScript to continue using this application.

Compare $IONS vs $IOVA | Chartloom

Compare

$IONS vs $IOVA

Ionis Pharmaceuticals Inc · Iovance Biotherapeutics Inc

IONS

Ionis Pharmaceuticals Inc

IOVA

Iovance Biotherapeutics Inc

Compare $IONS vs $IOVA

Comparing Ionis Pharmaceuticals Inc and Iovance Biotherapeutics Inc

IONSIonis Pharmaceuticals Inc

IOVAIovance Biotherapeutics Inc

IONSIonis Pharmaceuticals Inc

Market cap

$7.52B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

7.89x

Rev growth (TTM)

-7.4%

YTD performance

-43.2%

52W performance

-35.3%

FCF yield

-7.5%

IOVAIovance Biotherapeutics Inc

Market cap

$6.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.69x

Rev growth (TTM)

34.5%

YTD performance

480.2%

52W performance

544.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IONS

IOVA

Detailed metrics comparison

IONS

Ionis Pharmaceuticals Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

IONS$7.52B

IOVA$6.53B

Enterprise Value

IONS$9.09B

IOVA$6.42B

Price

IONS$45.28

IOVA$14.62

P/E Ratio

IONSN/A

IOVAN/A

P/S Ratio

IONS8.61x

IOVA20.09x

EV/Sales

IONS10.40x

IOVA19.75x

EV/EBITDA

IONS262.66x

IOVA0.00x

P/B Ratio

IONS16.45x

IOVA8.75x

P/FCF Ratio

IONSN/A

IOVAN/A

EV/FCF

IONS-16.20x

IOVA-21.65x

PEG Ratio

IONSN/A

IOVAN/A

Forward P/E (NTM)

IONSN/A

IOVAN/A

Forward P/S (NTM)

IONS7.89x

IOVA12.69x

Revenue (TTM)

IONS$874M

IOVA$325M

Revenue Growth (YoY)

IONS-7.4%

IOVA34.5%

Forward Rev Growth

IONS51.4%

IOVA39.2%

Gross Margin (TTM)

IONS98.2%

IOVA48.4%

Operating Margin (TTM)

IONS0.0%

IOVA0.0%

EBITDA Margin (TTM)

IONS-66.3%

IOVA-79.8%

Net Margin (TTM)

IONS-64.7%

IOVA-89.1%

FCF Margin (TTM)

IONS-64.2%

IOVA-91.2%

Net Income (TTM)

IONS$-565M

IOVA$-290M

FCF (TTM)

IONS$-561M

IOVA$-296M

EPS (TTM)

IONS-$3.42

IOVA-$0.64

ROE (TTM)

IONS-11092.0%

IOVA-4051.0%

ROA (TTM)

IONS-1739.0%

IOVA-3165.0%

ROIC (TTM)

IONS-2175.0%

IOVA-4047.0%

Cash

IONS$350M

IOVA$111M

Debt

IONS$1.91B

IOVA$0

Net Cash/Debt

IONS$-1.56B

IOVA$111M

Current Ratio (TTM)

IONS7.89x

IOVA4.35x

Quick Ratio (TTM)

IONS7.73x

IOVA3.74x

Debt/Equity (TTM)

IONS4.35x

IOVA0.00x

Debt/Assets (TTM)

IONS0.0%

IOVA0.0%

Interest Coverage (TTM)

IONSN/A

IOVAN/A

Net Debt/EBITDA (TTM)

IONS0.00x

IOVA0.00x

Beta

IONS0.38

IOVA0.76

52W Performance

IONS-35.3%

IOVA544.1%

YTD Performance

IONS-43.2%

IOVA480.2%

% from 52W High

IONS-47.8%

IOVA-4.4%

% from 52W Low

IONS6.2%

IOVA730.7%

Asset Turnover (TTM)

IONS0.27x

IOVA0.36x

FCF Yield (TTM)

IONS-7.5%

IOVA-4.5%

Earnings Yield (TTM)

IONS-7.5%

IOVA-4.4%

Dividend Yield (TTM)

IONSN/A

IOVAN/A

Rule of 40

IONS-71.6

IOVA-56.7

EV/GP/RG

IONS0.95

IOVA0.68

Ticker research

View IONS research View IOVA research

Metric	IONS Ionis Pharmaceuticals Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$7.52B	$6.53B
Enterprise Value	$9.09B	$6.42B
Price	$45.28	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	8.61x	20.09x
EV/Sales	10.40x	19.75x
EV/EBITDA	262.66x	0.00x
P/B Ratio	16.45x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.20x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	7.89x	12.69x
Revenue & Growth
Revenue (TTM)	$874M	$325M
Revenue Growth (YoY)	-7.4%	34.5%
Forward Rev Growth	51.4%	39.2%
Profitability
Gross Margin (TTM)	98.2%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-66.3%	-79.8%
Net Margin (TTM)	-64.7%	-89.1%
FCF Margin (TTM)	-64.2%	-91.2%
Net Income (TTM)	$-565M	$-290M
FCF (TTM)	$-561M	$-296M
EPS (TTM)	-$3.42	-$0.64
ROE (TTM)	-11092.0%	-4051.0%
ROA (TTM)	-1739.0%	-3165.0%
ROIC (TTM)	-2175.0%	-4047.0%
Financial Health
Cash	$350M	$111M
Debt	$1.91B	$0
Net Cash/Debt	$-1.56B	$111M
Current Ratio (TTM)	7.89x	4.35x
Quick Ratio (TTM)	7.73x	3.74x
Debt/Equity (TTM)	4.35x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.38	0.76
52W Performance	-35.3%	544.1%
YTD Performance	-43.2%	480.2%
% from 52W High	-47.8%	-4.4%
% from 52W Low	6.2%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.36x
FCF Yield (TTM)	-7.5%	-4.5%
Earnings Yield (TTM)	-7.5%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-71.6	-56.7
EV/GP/RG	0.95	0.68
Ticker research	View IONS research	View IOVA research

Valuation

P/S Ratio

IONS

8.61x

IOVA

20.09x

EV/FCF

IOVA

-21.65x

IONS

-16.20x

Growth & revenue

Revenue Growth TTM

IOVA

34.5%

IONS

-7.4%

Forward Revenue Growth

IONS

51.4%

IOVA

39.2%

Profitability & performance

Gross Margin

IONS

98.2%

IOVA

48.4%

ROE

IOVA

-4051.0%

IONS

-11092.0%

FCF Yield %

IOVA

-4.5%

IONS

-7.5%

52-Week Performance

IOVA

544.1%

IONS

-35.3%

Detailed metrics comparison

IONS

Ionis Pharmaceuticals Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

IONS$7.52B

IOVA$6.53B

Enterprise Value

IONS$9.09B

IOVA$6.42B

Price

IONS$45.28

IOVA$14.62

P/E Ratio

IONSN/A

IOVAN/A

P/S Ratio

IONS8.61x

IOVA20.09x

EV/Sales

IONS10.40x

IOVA19.75x

EV/EBITDA

IONS262.66x

IOVA0.00x

P/B Ratio

IONS16.45x

IOVA8.75x

P/FCF Ratio

IONSN/A

IOVAN/A

EV/FCF

IONS-16.20x

IOVA-21.65x

PEG Ratio

IONSN/A

IOVAN/A

Forward P/E (NTM)

IONSN/A

IOVAN/A

Forward P/S (NTM)

IONS7.89x

IOVA12.69x

Revenue (TTM)

IONS$874M

IOVA$325M

Revenue Growth (YoY)

IONS-7.4%

IOVA34.5%

Forward Rev Growth

IONS51.4%

IOVA39.2%

Gross Margin (TTM)

IONS98.2%

IOVA48.4%

Operating Margin (TTM)

IONS0.0%

IOVA0.0%

EBITDA Margin (TTM)

IONS-66.3%

IOVA-79.8%

Net Margin (TTM)

IONS-64.7%

IOVA-89.1%

FCF Margin (TTM)

IONS-64.2%

IOVA-91.2%

Net Income (TTM)

IONS$-565M

IOVA$-290M

FCF (TTM)

IONS$-561M

IOVA$-296M

EPS (TTM)

IONS-$3.42

IOVA-$0.64

ROE (TTM)

IONS-11092.0%

IOVA-4051.0%

ROA (TTM)

IONS-1739.0%

IOVA-3165.0%

ROIC (TTM)

IONS-2175.0%

IOVA-4047.0%

Cash

IONS$350M

IOVA$111M

Debt

IONS$1.91B

IOVA$0

Net Cash/Debt

IONS$-1.56B

IOVA$111M

Current Ratio (TTM)

IONS7.89x

IOVA4.35x

Quick Ratio (TTM)

IONS7.73x

IOVA3.74x

Debt/Equity (TTM)

IONS4.35x

IOVA0.00x

Debt/Assets (TTM)

IONS0.0%

IOVA0.0%

Interest Coverage (TTM)

IONSN/A

IOVAN/A

Net Debt/EBITDA (TTM)

IONS0.00x

IOVA0.00x

Beta

IONS0.38

IOVA0.76

52W Performance

IONS-35.3%

IOVA544.1%

YTD Performance

IONS-43.2%

IOVA480.2%

% from 52W High

IONS-47.8%

IOVA-4.4%

% from 52W Low

IONS6.2%

IOVA730.7%

Asset Turnover (TTM)

IONS0.27x

IOVA0.36x

FCF Yield (TTM)

IONS-7.5%

IOVA-4.5%

Earnings Yield (TTM)

IONS-7.5%

IOVA-4.4%

Dividend Yield (TTM)

IONSN/A

IOVAN/A

Rule of 40

IONS-71.6

IOVA-56.7

EV/GP/RG

IONS0.95

IOVA0.68

Ticker research

View IONS research View IOVA research

Metric	IONS Ionis Pharmaceuticals Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$7.52B	$6.53B
Enterprise Value	$9.09B	$6.42B
Price	$45.28	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	8.61x	20.09x
EV/Sales	10.40x	19.75x
EV/EBITDA	262.66x	0.00x
P/B Ratio	16.45x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.20x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	7.89x	12.69x
Revenue & Growth
Revenue (TTM)	$874M	$325M
Revenue Growth (YoY)	-7.4%	34.5%
Forward Rev Growth	51.4%	39.2%
Profitability
Gross Margin (TTM)	98.2%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-66.3%	-79.8%
Net Margin (TTM)	-64.7%	-89.1%
FCF Margin (TTM)	-64.2%	-91.2%
Net Income (TTM)	$-565M	$-290M
FCF (TTM)	$-561M	$-296M
EPS (TTM)	-$3.42	-$0.64
ROE (TTM)	-11092.0%	-4051.0%
ROA (TTM)	-1739.0%	-3165.0%
ROIC (TTM)	-2175.0%	-4047.0%
Financial Health
Cash	$350M	$111M
Debt	$1.91B	$0
Net Cash/Debt	$-1.56B	$111M
Current Ratio (TTM)	7.89x	4.35x
Quick Ratio (TTM)	7.73x	3.74x
Debt/Equity (TTM)	4.35x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.38	0.76
52W Performance	-35.3%	544.1%
YTD Performance	-43.2%	480.2%
% from 52W High	-47.8%	-4.4%
% from 52W Low	6.2%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	0.36x
FCF Yield (TTM)	-7.5%	-4.5%
Earnings Yield (TTM)	-7.5%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-71.6	-56.7
EV/GP/RG	0.95	0.68
Ticker research	View IONS research	View IOVA research